How can biologically-based modeling of arsenic kinetics and dynamics inform the risk assessment process? - A workshop review.
暂无分享,去创建一个
Harvey J Clewell | Barbara D Beck | Elaina M Kenyon | Hisham El-Masri | Rory B Conolly | Walter T Klimecki | B. D. Beck | H. Clewell | R. Conolly | H. El-Masri | E. Kenyon | W. Klimecki
[1] E. Dubé,et al. Arsenic toxicity at low doses: epidemiological and mode of action considerations. , 2004, Toxicology and applied pharmacology.
[2] A. Poklis,et al. Estimation of the body burden of arsenic in a child fatally poisoned by arsenite weedkiller. , 1989, Journal of analytical toxicology.
[3] M. Vahter,et al. Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. , 2008, Environmental research.
[4] Takahiko Yoshida,et al. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. , 2004, Toxicology and applied pharmacology.
[5] L. Marnett,et al. Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. , 2005, Chemical research in toxicology.
[6] F. Jasmine,et al. Arsenic Metabolism, Genetic Susceptibility, and Risk of Premalignant Skin Lesions in Bangladesh , 2007, Cancer Epidemiology Biomarkers & Prevention.
[7] M. Vahter. Mechanisms of arsenic biotransformation. , 2002, Toxicology.
[8] Lizhi Yu,et al. Developmentally Restricted Genetic Determinants of Human Arsenic Metabolism: Association between Urinary Methylated Arsenic and CYT19 Polymorphisms in Children , 2005, Environmental health perspectives.
[9] Y. Hsueh,et al. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. , 2007, Toxicology and applied pharmacology.
[10] Thomas J. Smith,et al. Arsenic methylation and bladder cancer risk in Taiwan , 2003, Cancer Causes & Control.
[11] Thomas J. Smith,et al. Arsenic Methylation and Skin Cancer Risk in Southwestern Taiwan , 2003, Journal of occupational and environmental medicine.
[12] Y. Hsueh,et al. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[13] M. Bates,et al. Please Scroll down for Article Journal of Toxicology and Environmental Health, Part A , 2022 .
[14] S. Hirano,et al. A new metabolic pathway of arsenite: arsenic–glutathione complexes are substrates for human arsenic methyltransferase Cyt19 , 2005, Archives of Toxicology.
[15] J. Feldmann,et al. Sulfur-containing arsenical mistaken for dimethylarsinous acid [DMA(III)] and identified as a natural metabolite in urine: major implications for studies on arsenic metabolism and toxicity. , 2004, Chemical research in toxicology.
[16] F. Stagnitti,et al. Arsenic contamination in Bangladesh groundwater: A major environmental and social disaster , 2002, International journal of environmental health research.
[17] W. Cullen,et al. Determination of trivalent methylated arsenicals in biological matrices. , 2001, Toxicology and applied pharmacology.
[18] C. Klein,et al. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk? , 2005, Toxicology and applied pharmacology.
[19] W. Cullen,et al. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells , 2000, Archives of Toxicology.
[20] S. Fukushima,et al. The Urinary Excretion of Arsenic Metabolites After a Single Oral Administration of Dimethylarsinic Acid to Rats , 1997, Archives of environmental contamination and toxicology.
[21] L. Fanton,et al. Arsenic speciation in human organs following fatal arsenic trioxide poisoning--a case report. , 1999, Clinical chemistry.
[22] H. Aposhian,et al. Arsenic toxicology: five questions. , 2006, Chemical research in toxicology.
[23] L. D. Del Razo,et al. Dose-dependent effects on tissue distribution and metabolism of dimethylarsinic acid in the mouse after intravenous administration. , 2000, Toxicology.
[24] Mitsuru Mori,et al. Magnitude of arsenic toxicity in tube-well drinking water in Bangladesh and its adverse effects on human health including cancer: evidence from a review of the literature. , 2003, Asian Pacific journal of cancer prevention : APJCP.
[25] X Chris Le,et al. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. , 2002, Chemical research in toxicology.
[26] F. Parvez,et al. Folate, Homocysteine, and Arsenic Metabolism in Arsenic-Exposed Individuals in Bangladesh , 2005, Environmental health perspectives.
[27] B. D. Beck,et al. Methylated Arsenicals: The Implications of Metabolism and Carcinogenicity Studies in Rodents to Human Risk Assessment , 2006, Critical reviews in toxicology.
[28] Y. Hsueh,et al. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. , 2005, Toxicology and applied pharmacology.
[29] S. Waters,et al. Arsenic (+3 Oxidation State) Methyltransferase and the Methylation of Arsenicals , 2007, Experimental biology and medicine.
[30] J. Yager,et al. Physiologically Based Pharmacokinetic Modeling of Arsenic in the Mouse , 2004, Journal of toxicology and environmental health. Part A.
[31] A. J. Gandolfi,et al. Arsenite and monomethylarsonous acid generate oxidative stress response in human bladder cell culture. , 2006, Toxicology and applied pharmacology.
[32] W. Goessler,et al. Metabolism of Low-Dose Inorganic Arsenic in a Central European Population: Influence of Sex and Genetic Polymorphisms , 2007, Environmental health perspectives.
[33] C. Tseng,et al. Arsenic Methylation, Urinary Arsenic Metabolites and Human Diseases: Current Perspective , 2007, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[34] R. Tennant,et al. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. , 1997, Mutation research.
[35] A. Natarajan,et al. A unique metabolism of inorganic arsenic in native Andean women. , 1995, European journal of pharmacology.
[36] C. J. Chen,et al. Arsenic methylation capacity and skin cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[37] X. Le,et al. Arsenic-induced bladder cancer in an animal model. , 2007, Toxicology and applied pharmacology.
[38] H. Aposhian,et al. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. , 2004, Toxicology and applied pharmacology.
[39] D. Christiani,et al. Polymorphisms in GSTT1 and p53 and urinary transitional cell carcinoma in south-western Taiwan: A preliminary study , 2004, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[40] L. Gil,et al. CYP1A1 and GSTM1 genetic polymorphisms in lung cancer populations exposed to arsenic in drinking water , 2005, Xenobiotica; the fate of foreign compounds in biological systems.
[41] X. Le,et al. Binding of Dimethylarsinous Acid to Cys-13α of Rat Hemoglobin Is Responsible for the Retention of Arsenic in Rat Blood , 2007 .
[42] H. El-Masri,et al. Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites , 2008, Journal of Pharmacokinetics and Pharmacodynamics.
[43] D. Chakraborti,et al. Pattern of Excretion of Arsenic Compounds [Arsenite, Arsenate, MMA(V), DMA(V)] in Urine of Children Compared to Adults from an Arsenic Exposed Area in Bangladesh , 2003, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.
[44] A. Hartwig,et al. Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg. , 2003, DNA repair.
[45] Andre E. Nel,et al. How Exposure to Environmental Tobacco Smoke, Outdoor Air Pollutants, and Increased Pollen Burdens Influences the Incidence of Asthma , 2006, Environmental health perspectives.
[46] Soile Tapio,et al. Arsenic in the aetiology of cancer. , 2006, Mutation research.
[47] Y. Hsueh,et al. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. , 2007, Toxicology and applied pharmacology.
[48] R. Ryhage,et al. Biotransformation of dimethylarsinic acid in mouse, hamster and man , 1987, Journal of applied toxicology : JAT.
[49] S. Fukushima,et al. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. , 2002, Carcinogenesis.
[50] E. Kenyon,et al. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate. , 2003, Toxicology and applied pharmacology.
[51] X. Le,et al. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid , 2001 .
[52] K. Harrington-Brock,et al. Relative genotoxic potency of arsenic and its methylated metabolites. , 1997, Mutation research.
[53] S. Waters,et al. Elucidating the pathway for arsenic methylation. , 2004, Toxicology and applied pharmacology.
[54] B. Walsh,et al. Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles. , 2003, Chemical research in toxicology.
[55] F. Parvez,et al. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. , 2006, The American journal of clinical nutrition.
[56] R Julian Preston,et al. Quantitation of molecular endpoints for the dose-response component of cancer risk assessment. , 2002, Toxicologic pathology.
[57] Harvey J Clewell,et al. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report. , 2007, Toxicology and applied pharmacology.
[58] Ravi P Subramaniam,et al. Uncertainties in the CIIT Model for Formaldehyde‐Induced Carcinogenicity in the Rat: A Limited Sensitivity Analysis–I , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[59] L. D. Del Razo,et al. Urinary Trivalent Methylated Arsenic Species in a Population Chronically Exposed to Inorganic Arsenic , 2004, Environmental health perspectives.
[60] S. Waters,et al. Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype. , 2005, Toxicology and applied pharmacology.
[61] Eric D. Wieben,et al. Human Arsenic Methyltransferase (AS3MT) Pharmacogenetics , 2006, Journal of Biological Chemistry.
[62] R. Nagle,et al. Effects of acute and chronic arsenic exposure of human-derived keratinocytes in an In Vitro human skin equivalent system: a novel model of human arsenicism. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.
[63] Thomas J. Smith,et al. A case-control study of GST polymorphisms and arsenic related skin lesions , 2007, Environmental health : a global access science source.
[64] Julia S Kimbell,et al. Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[66] Julia S Kimbell,et al. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[67] E. Kenyon,et al. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. , 1998, Journal of toxicology and environmental health. Part A.
[68] J. Spalding,et al. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. , 1998, The American journal of pathology.
[69] H. Roels,et al. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man , 1981, International archives of occupational and environmental health.
[70] T. Rossman. Mechanism of arsenic carcinogenesis: an integrated approach. , 2003, Mutation research.